Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
05/2003
05/15/2003US20030091654 Dietetics, antidiabetic agents; using chromium complex
05/15/2003US20030091648 Hydrophilic core overcoated with hydrophobic hot melt lipid; for water soluble vitamins
05/15/2003US20030091630 Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
05/15/2003US20030091620 Transdermal drug delivery systems containing quaternary ammonium salts and methods of using the same
05/15/2003US20030091611 Antiproliferative agents ; antiinflammatory agents; insertable stent
05/15/2003US20030091553 Use of histamine to treat liver disease
05/15/2003US20030091549 Antiinflammatory agents; inflammatory bowel disease; gastrointestinal disorders
05/15/2003US20030091530 Preventives and/or remedies for hyperphosphatemia
05/15/2003US20030091528 Mixing an opaque mixture under pressure
05/15/2003US20030091518 Mixture containing plant extracts and oils
05/15/2003US20030091505 Antiserotonine agents; central nervous system disorders
05/15/2003CA2669810A1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase
05/15/2003CA2466278A1 Rehydrating formulation
05/15/2003CA2466232A1 Systems for delivery and release of angiotensin-(1-7)
05/15/2003CA2466198A1 Somatic cell derived embryonic stem cells and their differentiated progenies
05/15/2003CA2466145A1 Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
05/15/2003CA2466030A1 Intraorally disintegrating valdecoxib compositions prepared by fluid bed granulation process
05/15/2003CA2466022A1 Probiotic compositions
05/15/2003CA2465950A1 Endocrine pancreas differentiation of adipose tissue-derived stromal cells and uses thereof
05/15/2003CA2465945A1 Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
05/15/2003CA2465711A1 Aminopyrimidines and pyridines
05/15/2003CA2465695A1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase
05/15/2003CA2465239A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/15/2003CA2465186A1 Methods for treating depression and other cns disorders using enantiomerically enriched desmethyl- and didesmethyl-metabolites of citalopram
05/15/2003CA2464717A1 Compounds and methods for treating transplant rejection
05/15/2003CA2464685A1 Novel mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (asbt) and taurocholate uptake
05/15/2003CA2464531A1 Soluble cd40l(cd154) as a prognostic marker of atherosclerotic diseases
05/15/2003CA2462462A1 Peptides acting as both glp-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
05/15/2003CA2462158A1 Method and composition for preventing or reducing the symptoms of insulin resistance syndrome
05/15/2003CA2459745A1 Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
05/14/2003EP1310797A2 Method of monitoring neuroprotective treatment
05/14/2003EP1310571A2 A Method of detecting and/or identifying adeno-associated virus (AVV) sequences and isolating novel sequences identified thereby
05/14/2003EP1310554A1 Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin d metabolism and dnas encoding the same
05/14/2003EP1310509A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
05/14/2003EP1310505A1 Amine salt of lignan compound
05/14/2003EP1310498A2 Pyrazoloquinolinone derivatives as protein kinase C inhibitors
05/14/2003EP1310494A1 PPAR (delta) ACTIVATORS
05/14/2003EP1310493A1 N-adamantylalkyl benzamide derivates as p2x7-receptor antagonists
05/14/2003EP1310262A1 Topical composition having undifferentiated plant seed cells and method for using same
05/14/2003EP1310259A2 Formulation comprising a biphosphonate and an absorption enhancing agent for the treatment of osteoporosis
05/14/2003EP1310247A1 (+)-ephedrine as a sympathomimetic drug
05/14/2003EP1310173A2 Composition for providing nutrition to diabetics
05/14/2003EP1309706A2 Modulation of stem cell differentiation
05/14/2003EP1309699A2 Elongase genes and uses thereof
05/14/2003EP1309697A2 Regulation of human 11 beta-hydroxysteroid dehydrogenase 1-like enzyme
05/14/2003EP1309684A2 Polynucleotides and polypeptides encoded thereby
05/14/2003EP1309616A1 Integrin binding motif containing peptides and methods of treating skeletal diseases
05/14/2003EP1309596A2 Heterocyclic compounds useful as inhibitors of tyrosine kinases
05/14/2003EP1309594A1 Benzimidazole derivatives, preparation and therapeutic use thereof
05/14/2003EP1309589A2 Urea compounds and methods of uses
05/14/2003EP1309587A1 Cinnoline compounds
05/14/2003EP1309575A1 Biphenyl derivatives and their use as ppar-gamma receptor activators
05/14/2003EP1309564A2 Arylethene-sulfonamides, their preparation and their use as endothelin antagonists
05/14/2003EP1309563A1 Heterocyclic-hydroxyimino-fluorenes and their use for inhibiting protein kinases
05/14/2003EP1309560A1 Pyridine derivatives as inhibitors of p38
05/14/2003EP1309552A1 Compounds and inhibitors of phospholipases
05/14/2003EP1309551A1 Indoline derivatives as 5ht2c antagonists
05/14/2003EP1309544A1 Compounds acting as melanocortin receptor ligands
05/14/2003EP1309532A1 Method for obtaining cocoa bean polyphenol extracts, resulting extracts and uses thereof
05/14/2003EP1309373A2 Method and composition for altering a t cell mediated pathology
05/14/2003EP1309347A2 Method and composition for altering a b cell mediated pathology
05/14/2003EP1309340A1 High mannose proteins and methods of making high mannose proteins
05/14/2003EP1309329A2 Therapeutic combination of a cetp inhibitor and atorvastatin
05/14/2003EP1309325A1 Anticonvulsant derivatives useful for the treatment of depression
05/14/2003EP1309324A2 Anticonvulsant derivatives useful for treating and preventing the development of type ii diabetes mellitus and syndrome x
05/14/2003EP1309321A1 Compositions and methods for inhibiting islet dysfunction and autoimmune disorders
05/14/2003EP1309250A2 Nutritional supplement for the management of weight
05/14/2003EP1180105B1 Substituted aza-oxindole derivatives
05/14/2003EP1175157A4 Low molecular weight polymannuronate
05/14/2003EP1165595B1 Liver specific bile acid derivatives of the glucocorticoid antagonist ru486
05/14/2003EP1140189B1 Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications
05/14/2003EP1112266B1 Substituted 4-amino-2-aryl-pyrimidines, their production and use and pharmaceutical preparations containing same
05/14/2003EP1102746B1 Substituted phenylamidines with antithrombotic action
05/14/2003EP1021194B1 New improved formulation for treatment of osteoporosis
05/14/2003EP0970077B1 Improved method for producing thiazolidinediones, and new thiazolidinediones
05/14/2003EP0958382B1 Novel method for testing the differentiation status in pancreatic cells of a mammal
05/14/2003EP0946550A4 PREPARATION OF 1S- 1a,2b,3b,4a(S*)]]-4- 7- 1-(3-CHLORO-2-THIENYL) METHYL]PROPYL]AMINO]-3H-IMIDAZO 4,5-b]PYRIDIN-3-yl]-N-ETHYL-2,3-DIHYDROXYCYCLOPENTANECARBOXAMIDE
05/14/2003EP0934313B1 N-substituted azaheterocyclic compounds
05/14/2003EP0815255B1 Hormone and growth factor phosphoglycan mimetics from mycobacterium vaccae
05/14/2003CN1418219A Glucopyranosyloxy benzylbenzene derivatives, medicinal compositions containing the same and intermediates for the prepararation of the derivatives
05/14/2003CN1418216A Novel 2,3,4,5-tetrahydro-1H-[1,4] diazepino [1,7a]indole compound
05/14/2003CN1418215A Substituted beta-carbolines with IKB-kinase inhibiting activity
05/14/2003CN1418211A 苯并咪唑衍生物 Benzimidazole derivatives
05/14/2003CN1418203A Percyquinnin, Process for its production and its use pharmaceutical
05/14/2003CN1418199A Pyrimidine-4-one derivatives as LDL-PLA2 inhibitors
05/14/2003CN1418198A Crystalline salts of 7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl (methylsulfonyl)amino] pyrimidin-5-yl]-(3R5S)-3,5-dihydroxyhept-6-enojc acid
05/14/2003CN1418197A Piperidine and piperazine substituted N-hydroxyformamides as inhibitors of metalloproteinases
05/14/2003CN1418192A Pharmaceutical compositions containing azetidine derivatives novel azetidine derivatives and preparation thereof
05/14/2003CN1418191A Novel thiourea derivatives and the pharmaceutical compositions containing thd same
05/14/2003CN1418185A Aniline-derived ligands for thyroid receptor
05/14/2003CN1418113A medicinal aerosol formulation
05/14/2003CN1418111A Novel Ligands and method for preparing same
05/14/2003CN1418109A Drugs for complications of diabetes and neuropathy and utilization thereof
05/14/2003CN1418102A 激素替代疗法 Hormone replacement therapy
05/14/2003CN1418091A Pharmaceutical preparations
05/14/2003CN1418089A Pharmaceutical composition of glycogen phosphorylase inhibitors
05/14/2003CN1416879A Antilipemic Chinese medicine
05/14/2003CN1416854A Diabetes treating medicine and its prepn
05/14/2003CN1416831A Blood fat-eliminating medicine pill and its prepn
05/14/2003CN1416806A Local composition with undifferentiated plant seed cell and ifs usage
1 ... 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 ... 1298